Skip to main content
. 2018 Oct 26;97(43):e12843. doi: 10.1097/MD.0000000000012843

Table 5.

Subgroup analysis of efficacy effect sizes (e.g., change from baseline in SBP, change from baseline in DBP and percentage of patients who had uncontrolled blood pressure at baseline had controlled blood pressure (130/80 mm Hg)) according to concomitant therapy of EMPA on type 2 diabetes mellitus.

3.3.3.